1. Home
  2. IMRX vs FUND Comparison

IMRX vs FUND Comparison

Compare IMRX & FUND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immuneering Corporation

IMRX

Immuneering Corporation

HOLD

Current Price

$5.74

Market Cap

340.7M

Sector

Health Care

ML Signal

HOLD

FUND

Sprott Focus Trust Inc.

HOLD

Current Price

$10.16

Market Cap

303.4M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMRX
FUND
Founded
2008
1988
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
340.7M
303.4M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
IMRX
FUND
Price
$5.74
$10.16
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$17.20
N/A
AVG Volume (30 Days)
1.3M
23.8K
Earning Date
05-04-2026
01-01-0001
Dividend Yield
N/A
6.64%
EPS Growth
37.75
N/A
EPS
N/A
0.93
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$10.99
Revenue Growth
N/A
N/A
52 Week Low
$1.67
$7.14
52 Week High
$10.08
$10.44

Technical Indicators

Market Signals
Indicator
IMRX
FUND
Relative Strength Index (RSI) 59.88 55.48
Support Level $5.11 $9.87
Resistance Level $7.67 $10.36
Average True Range (ATR) 0.45 0.16
MACD 0.05 -0.01
Stochastic Oscillator 44.47 60.54

Price Performance

Historical Comparison
IMRX
FUND

About IMRX Immuneering Corporation

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

About FUND Sprott Focus Trust Inc.

Sprott Focus Trust Inc is a diversified closed-end investment company. Its primary investment objective is long-term capital growth. To achieve its objective, the Fund may invest its assets in equity securities and in direct obligations of the U.S. Government or its agencies and in the non-convertible preferred stocks & debt securities of domestic and foreign companies. It invests in various sectors, of which Materials, Financials, Energy, Information technology sector account for the majority weightage.

Share on Social Networks: